November 13, 2025 · Form 4 insider transaction
SANDERS MACHELLE sold 9,600 shares of BioCryst Pharmaceuticals, Inc. at $7.14 per share, a transaction worth $68.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
These shares were sold pursuant to a plan adopted by the Reporting Person on August 14, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The sale occurred automatically and does not represent a discretionary transaction by the Reporting Person.